Various inflammatory cytokines such as interleukin (IL)-6, IL-1β, and interferon (IFN)-γ have been proven to be associated with the OLP pathogenesis [20–24] and may be used as biomarkers in serum and saliva for monitoring of disease activity and therapeutic response [25]. Here, IL1B is linked to oral lichen planus.